allencooper
New member
Armodafinil, a wakefulness-promoting agent, should be used cautiously during pregnancy due to limited safety data. Animal studies suggest potential adverse effects on fetal development, including increased rates of fetal malformations and decreased fetal weight. Pregnant individuals considering Armodafinil should consult healthcare professionals to weigh potential risks against benefits. To know in details about taking Armodafinil during pregnancy read this blog at HealthMatter .